- Home
- LICN vs INM Comparison
LICN vs INM Comparison
Compare LICN & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LICN
- INM
- Stock Information
- Founded
- LICN 2004
- INM 1981
- Country
- LICN China
- INM Canada
- Employees
- LICN N/A
- INM N/A
- Industry
- LICN
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- LICN
- INM Health Care
- Exchange
- LICN Nasdaq
- INM Nasdaq
- Market Cap
- LICN 3.1M
- INM 3.2M
- IPO Year
- LICN 2023
- INM N/A
- Fundamental
- Price
- LICN $4.44
- INM $2.75
- Analyst Decision
- LICN
- INM
- Analyst Count
- LICN 0
- INM 0
- Target Price
- LICN N/A
- INM N/A
- AVG Volume (30 Days)
- LICN 22.6K
- INM 5.7M
- Earning Date
- LICN 01-01-0001
- INM 05-12-2025
- Dividend Yield
- LICN N/A
- INM N/A
- EPS Growth
- LICN N/A
- INM N/A
- EPS
- LICN N/A
- INM N/A
- Revenue
- LICN $41,477,000.00
- INM $4,920,990.00
- Revenue This Year
- LICN N/A
- INM N/A
- Revenue Next Year
- LICN N/A
- INM N/A
- P/E Ratio
- LICN N/A
- INM N/A
- Revenue Growth
- LICN 4.32
- INM N/A
- 52 Week Low
- LICN $2.60
- INM $1.72
- 52 Week High
- LICN $488.00
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- LICN 53.94
- INM 46.31
- Support Level
- LICN $4.02
- INM $2.66
- Resistance Level
- LICN $4.41
- INM $2.97
- Average True Range (ATR)
- LICN 0.25
- INM 0.37
- MACD
- LICN 0.05
- INM -0.05
- Stochastic Oscillator
- LICN 92.57
- INM 15.12
About LICN Lichen China Limited
Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.